Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $4.59 Billion |
|---|---|
| Enterprise Value | $4.58 Billion |
| Earnings per Share | $-1.49 |
| Beta | 0 |
| Outstanding Shares | 1,683,338,237 |
| P/E Ratio | -1.99 |
|---|---|
| PEG | -6.79 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 782.97 |
| Enterprise Value to EBIT | -62.06 |
| Enterprise Value to Net Income | -74 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0.04 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Sensorion SA is a clinical-stage biopharmaceutical firm based in Montpellier, France, specializing in the development of therapies for inner ear disorders. Their key initiatives include gene therapy programs: OTOF-GT, designed to restore...